SCHEMBL3356574

SCHEMBL3356574

N#Cc1c(N)nc(OCc2cccc(C(=O)O)c2)c(C#N)c1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 7/20 0.61
MRGPRX4 Q96LA9 8/20 0.54
NR4A2 P43354 1/20 0.49
ADORA3 P0DMS8 1/20 0.48
ADORA2A P29274 1/20 0.48
SQOR Q9Y6N5 1/20 0.48
ACMSD Q8TDX5 1/20 0.48
IKBKB O14920 1/20 0.48
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
MITF O75030 1/20 0.46
TP53 P04637 1/20 0.46
HPGD P15428 1/20 0.46
XBP1 P17861 1/20 0.46
NFKB1 P19838 1/20 0.46
RAB9A P51151 1/20 0.46
NFKB2 Q00653 1/20 0.46
KMT2A Q03164 1/20 0.46
RELA Q04206 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3331988 0.90 ADORA1 (0.53) ADORA1MRGPRX4MEN1TP53HPGD
SCHEMBL3359530 0.89 ADORA1 (0.63) ADORA1MRGPRX4ADORA2ASQOR
SCHEMBL7019633 0.83 IKBKB (0.51) ADORA1ADORA3ADORA2AIKBKBMEN1
SCHEMBL923363 0.82 ADORA1 (0.50) ADORA1MRGPRX4ADORA3ADORA2A
SCHEMBL7016113 0.79 ADORA1 (0.55) ADORA1ADORA3ADORA2ASQORIKBKB
SCHEMBL245416 0.79 ADORA1 (0.86) ADORA1ADORA3ADORA2AACMSD
SCHEMBL3361524 0.79 ADORA1 (0.65) ADORA1MRGPRX4ADORA3MEN1TP53
SCHEMBL3550981 0.79 ADORA1 (0.60) ADORA1ADORA3ADORA2ASQORMEN1
SCHEMBL244652 0.79 ADORA1 (0.83) ADORA1
SCHEMBL3545741 0.78 RXFP1 (0.55) ADORA1ADORA3ADORA2ASQORMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-12 US disclosed
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2016-05-12 US disclosed
US-9187428-B2 Substituted dicyanopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-17 US disclosed
US-9187428-B2 Substituted dicyanopyridines and use thereof BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-11-17 US disclosed
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-08-15 US disclosed
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2013-08-15 US disclosed
WO-2012000945-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2012-01-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210795-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF QDPR, DPYD, DDC ADORA1 3010/4885MRGPRX4 2201/4885NR4A2 2185/4885
US-20160130230-A1 SUBSTITUTED DICYANOPYRIDINES AND USE THEREOF QDPR, DPYD, DDC ADORA1 3010/4885MRGPRX4 2201/4885NR4A2 2185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.